Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620714347> ?p ?o ?g. }
- W2620714347 endingPage "2283" @default.
- W2620714347 startingPage "2264" @default.
- W2620714347 abstract "Toll-like receptor 2 (TLR2) antagonists are key therapeutic targets because they inhibit several inflammatory diseases caused by surplus TLR2 activation. In this study, we identified two novel nonpeptide TLR2 antagonists, C11 and C13, through pharmacophore-based virtual screening. At 10 μm, the level of interleukin (IL)-8 inhibition by C13 and C11 in human embryonic kidney TLR2 overexpressing cells was comparable to the commercially available TLR2 inhibitor CU-CPT22. In addition, C11 and C13 acted in mouse macrophage-like RAW 264.7 cells as TLR2-specific inhibitors and did not suppress the tumor necrosis factor-α induction by TLR3 and TLR4 activators. Moreover, the two identified compounds bound directly to the human recombinant TLR2 ectodomain, during surface plasmon resonance analysis, and did not affect cell viability in a 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethonyphenol)-2-(4-sulfophenyl)-2H-tetrazolium assay. In total, two virtually screened molecules, C11 and C13, were experimentally proven to be effective as TLR2 antagonists, and thus will provide new insights into the structure of TLR2 antagonists, and pave the way for the development of TLR2-targeted drug molecules." @default.
- W2620714347 created "2017-06-09" @default.
- W2620714347 creator A5013544358 @default.
- W2620714347 creator A5020674417 @default.
- W2620714347 creator A5053830220 @default.
- W2620714347 creator A5054521593 @default.
- W2620714347 creator A5055744835 @default.
- W2620714347 creator A5068123081 @default.
- W2620714347 creator A5070919578 @default.
- W2620714347 creator A5075881953 @default.
- W2620714347 creator A5081832339 @default.
- W2620714347 creator A5082247143 @default.
- W2620714347 date "2017-07-01" @default.
- W2620714347 modified "2023-10-05" @default.
- W2620714347 title "Toll-like receptor 2 antagonists identified through virtual screening and experimental validation" @default.
- W2620714347 cites W1896283776 @default.
- W2620714347 cites W1896307869 @default.
- W2620714347 cites W1919748804 @default.
- W2620714347 cites W1969072247 @default.
- W2620714347 cites W1975580333 @default.
- W2620714347 cites W1975915404 @default.
- W2620714347 cites W1976623095 @default.
- W2620714347 cites W1979580921 @default.
- W2620714347 cites W1986240377 @default.
- W2620714347 cites W1993678336 @default.
- W2620714347 cites W1996671942 @default.
- W2620714347 cites W2001747259 @default.
- W2620714347 cites W2002262609 @default.
- W2620714347 cites W2004465286 @default.
- W2620714347 cites W2010453472 @default.
- W2620714347 cites W2019980219 @default.
- W2620714347 cites W2023218619 @default.
- W2620714347 cites W2026884617 @default.
- W2620714347 cites W2027065525 @default.
- W2620714347 cites W2035223344 @default.
- W2620714347 cites W2041791898 @default.
- W2620714347 cites W2043782165 @default.
- W2620714347 cites W2044172327 @default.
- W2620714347 cites W2051940924 @default.
- W2620714347 cites W2054889385 @default.
- W2620714347 cites W2056169996 @default.
- W2620714347 cites W2062267695 @default.
- W2620714347 cites W2070753604 @default.
- W2620714347 cites W2074978477 @default.
- W2620714347 cites W2075295096 @default.
- W2620714347 cites W2075426423 @default.
- W2620714347 cites W2094316817 @default.
- W2620714347 cites W2099099776 @default.
- W2620714347 cites W2101624429 @default.
- W2620714347 cites W2105649494 @default.
- W2620714347 cites W2107315506 @default.
- W2620714347 cites W2109491705 @default.
- W2620714347 cites W2110768898 @default.
- W2620714347 cites W2111260918 @default.
- W2620714347 cites W2120211786 @default.
- W2620714347 cites W2128572087 @default.
- W2620714347 cites W2129961630 @default.
- W2620714347 cites W2132262459 @default.
- W2620714347 cites W2134967712 @default.
- W2620714347 cites W2135732933 @default.
- W2620714347 cites W2138811813 @default.
- W2620714347 cites W2143516276 @default.
- W2620714347 cites W2152765405 @default.
- W2620714347 cites W2154706660 @default.
- W2620714347 cites W2156053468 @default.
- W2620714347 cites W2160544821 @default.
- W2620714347 cites W2164087707 @default.
- W2620714347 cites W2208203352 @default.
- W2620714347 cites W3175318380 @default.
- W2620714347 cites W4246077736 @default.
- W2620714347 doi "https://doi.org/10.1111/febs.14124" @default.
- W2620714347 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28570013" @default.
- W2620714347 hasPublicationYear "2017" @default.
- W2620714347 type Work @default.
- W2620714347 sameAs 2620714347 @default.
- W2620714347 citedByCount "14" @default.
- W2620714347 countsByYear W26207143472018 @default.
- W2620714347 countsByYear W26207143472019 @default.
- W2620714347 countsByYear W26207143472020 @default.
- W2620714347 countsByYear W26207143472022 @default.
- W2620714347 countsByYear W26207143472023 @default.
- W2620714347 crossrefType "journal-article" @default.
- W2620714347 hasAuthorship W2620714347A5013544358 @default.
- W2620714347 hasAuthorship W2620714347A5020674417 @default.
- W2620714347 hasAuthorship W2620714347A5053830220 @default.
- W2620714347 hasAuthorship W2620714347A5054521593 @default.
- W2620714347 hasAuthorship W2620714347A5055744835 @default.
- W2620714347 hasAuthorship W2620714347A5068123081 @default.
- W2620714347 hasAuthorship W2620714347A5070919578 @default.
- W2620714347 hasAuthorship W2620714347A5075881953 @default.
- W2620714347 hasAuthorship W2620714347A5081832339 @default.
- W2620714347 hasAuthorship W2620714347A5082247143 @default.
- W2620714347 hasBestOaLocation W26207143471 @default.
- W2620714347 hasConcept C1009742 @default.
- W2620714347 hasConcept C103697762 @default.
- W2620714347 hasConcept C136449434 @default.
- W2620714347 hasConcept C161624437 @default.
- W2620714347 hasConcept C170493617 @default.